pathwire
 
 
 
 
Whitepaper Download: The Secrets of Team Facilitation

_______________________________________________________ 

 

More and more businesses are turning to work teams to improve their products, processes and services-- and for good reason.  When work teams work well, they are more likely to produce creative breakthroughs and practical solutions than when employees labor alone.

 
Download article.

CDER Stresses Need for Better Supply Chain Risk Management

 ________________________________________________________

Willing parties, quality agreements and information from suppliers are all needed along with auditing programs in managing pharmaceutical supply chain risks, CDER Office of Compliance Division of Manufacturing and Product Quality (DMPQ) Director Richard Friedman stressed in addressing industry/regulator initiatives to strengthen supply chain integrity.

In managing risk, FDA understands that qualification is not going to be at the same rigor for each supplier, Friedman explained. 
 
Read complete article.

Medical Device Industry Pushes for Better Guidance

__________________________________________
 

A recent commitment the FDA made in exchange for receiving user fees from industry was to expedite its production of guidance documents to provide industry with a "roadmap" of how to bring a product from development to clearance for sale. 

"Having that roadmap, that document that says that from FDA's perspective, here's what we need, that gives us a lot of certainty and predictability, which are two of the things that our companies care about most," noted Medical Imaging and Technology Alliance executive director David Fisher.

 

Read complete article.
Poll Results: The quality of CAPA investigations and documentation varies between countries, markets, and/or cultures
 
_________________________________________________________ 
 
Last month, we issued a poll asking "Does the quality of CAPA investigations and documentation vary between countries, markets, and/or cultures?"
 
A 100% unanomous majority of respondants claimed yes.  Some of the top comments include:
 
"It all comes down to basic knowledge of how to run a process. Advanced countries are likely less able to do effective CAPA due to politics and financial pressure. Lesser developed countries are still able to use common sense."
 
"CAPA is very much a US-FDA concept."
 
"The more importance a BOH places on this activity, the deeper an investigation will tend to delve and the more rigorous will be the CAPA."
 
Corrective and Preventive Action: Upcoming Workshop in San Francisco 
 
_________________________________________________________ 
 
Our two day course is designed to meet the requirements mandated by the FDA to effectively investigate and locate causes and correct them.
 
Join us October 27-28 as we show you how to identify non-conformances (problems), how to assess and prioritize them based on risk, and how to implement a proper corrective and/or preventive action.
 
 

Monthly Newsletter 

PathWise, Inc. 

September 2010 

 image
 
 
Upcoming Events
 
CAPA Workshops for Life Sciences
 
This 2-day course, taught by former FDA Investigators, PathWise, and MasterControl industry experts, is designed to meet the requirements mandated by regulatory agencies to effectively investigate and locate causes and correct them.
 
 
 
October 27-28, 2010
San Francisco, CA
  

PathWise Webinars

 
Integrating ISO 14971 and ICH Q9 into the Quality System
 
This webinar provides insight into the necessary industry standards and offers meaningful techniques that risk management professionals can use to implement ISO 14971 and ICH Q9 into their quality system.

For more information or to purchase.
 
_________________
 

Integrating FDA and Trending Requirements into your CAPA System
 
This session offers attendees a "how-to" approach to effectively integrate the FDA's CAPA and Trending requirements, providing them with the skills necessary to develop a strong, sustainable and compliant CAPA system.

For more information or to purchase.

_________________
 
 
Conducting OOS and Non-Conformance Investigations
 
This webinar provides a process to effectively expedite and document OOS and non-conformance investigations to increase compliance in your organization. 

 
PathWise is pleased to announce the availability of our latest CFR, ICH and QSIT resource guides. These handy pocket-size booklets are an ideal way to keep your organization informed of the most current FDA regulations and guidelines.
 
Available guides include:
  • 21 CFR 820  - Quality System Regulations
  • 21 CFR 210-211 - Pharmaceutical GMPs
  • 21 CFR 111 - Dietary Supplements
  • 21 CFR 606 - Blood Industry
  • ICH Q9 - Risk Management for Pharmaceuticals
  • ICH Q10 - Quality Systems for Pharmaceuticals
  • QSIT for Medical Devices

Order Online

________________________________________________________________________________

                                                                  Facing an uphill battle?   

PathWise is a training and consulting firm that works with medical device, pharmaceutical and biotechnology companies in the areas of quality and compliance. We deliver the methodology and tools to ensure compliant, effective and efficient execution of quality system requirements. 
  
     Problem Solving                       Risk Management                         Documentation
           

CAPA                Quality Systems Regulation                   Auditing 

 
_______________________________________________________________________________________________________ 
 

          

                  Please visit us online at www.PathWise.com or call 866.580.PATH for more information